The pharmacokinetics and Concentration-QTc analysis of a new etomidate analog ET-26-HCl: a phase I trial in healthy Chinese subjects
Authors
- Lei Diao (ORCID: https://orcid.org/0000-0002-4103-7294)
- Xiangran Kong (ORCID: https://orcid.org/0009-0001-2705-4282)
- Guohai Su (ORCID: https://orcid.org/0000-0003-3403-1692)
- Xiaoran Yang
- Qing Wen (ORCID: https://orcid.org/0000-0002-6408-2370)
- Wenyu Zhang (ORCID: https://orcid.org/0000-0003-0010-3862)
- Hongyan Zhao (ORCID: https://orcid.org/0000-0002-7459-0336)
- Kun He (ORCID: https://orcid.org/0000-0002-1027-1854)
- Lize Li
Institutions
- Fosun Pharma (China) (CN)
- Jinan Central Hospital (CN)
- Buchang Pharma (China) (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-04-17
- DOI
- https://doi.org/10.3389/fphar.2025.1534717
- Primary Topic
- Cardiac electrophysiology and arrhythmias
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Shandong Province
- Young Scientists Fund